Verastem reported $0 in Stock for its fiscal quarter ending in March of 2022.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Cytokinetics USD 0 0 Dec/2023
Gilead Sciences USD 1.78B 40M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
Laboratory Of America USD 534.7M 13.2M Dec/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 125.59M 21.37M Dec/2025